Selected research
Market Analysis & Forecast
Global Calming Aids for Dogs Market Analysis and Forecast 2026-2032
Market perspective
The global Calming Aids for Dogs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Calming Aids for Dogs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Calming Aids for Dogs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Calming Aids for Dogs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Calming Aids for Dogs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Calming Aids for Dogs include Zoetis, Shangrao Chunyu Technology, Shandong Youmi Le Health Technology, Zatural, Wild One, Vetoquinol, ThunderEase, This Dog's Life and The Anxious Pet, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Calming Aids for Dogs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Calming Aids for Dogs, also provides the sales of main regions and countries. Of the upcoming market potential for Calming Aids for Dogs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Calming Aids for Dogs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Calming Aids for Dogs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Calming Aids for Dogs sales, projected growth trends, production technology, application and end-user industry.
Calming Aids for Dogs Segment by Company
Zoetis
Shangrao Chunyu Technology
Shandong Youmi Le Health Technology
Zatural
Wild One
Vetoquinol
ThunderEase
This Dog's Life
The Anxious Pet
Purina
Primo Pup
PetHonesty
Pet Remedy
Penelope's Bloom
NaturVet
Merck Animal Health
Maxxidog
Kradle
Koi CBD
King Kanine
Heavenly Hounds
FOMO Bones
Extract Labs
ElleVet Sciences
Elanco
Dr. Harvey’s
Ceva
Boehringer Ingelheim
Ark Naturals
Adaptil
Calming Aids for Dogs Segment by Type
Calming Collars
Calming Supplements
Pheromone Sprays
Anxiety Vests
Calming Aids for Dogs Segment by Application
Pet Shop
Pet Hospitals and Clinics
Household
Others
Calming Aids for Dogs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming Aids for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Calming Aids for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming Aids for Dogs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Calming Aids for Dogs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Calming Aids for Dogs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Calming Aids for Dogs sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Calming Collars
- Calming Supplements
- Pheromone Sprays
- Anxiety Vests
Applications
- Pet Shop
- Pet Hospitals and Clinics
- Household
- Others
Companies covered
- Zoetis
- Shangrao Chunyu Technology
- Shandong Youmi Le Health Technology
- Zatural
- Wild One
- Vetoquinol
- ThunderEase
- This Dog's Life
- The Anxious Pet
- Purina
- Primo Pup
- PetHonesty
- Pet Remedy
- Penelope's Bloom
- NaturVet
- Merck Animal Health
- Maxxidog
- Kradle
- Koi CBD
- King Kanine
- Heavenly Hounds
- FOMO Bones
- Extract Labs
- ElleVet Sciences
- Elanco
- Dr. Harvey’s
- Ceva
- Boehringer Ingelheim
- Ark Naturals
- Adaptil
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Calming Aids for Dogs Market by Type
- 1.2.1 Global Calming Aids for Dogs Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Calming Collars
- 1.2.3 Calming Supplements
- 1.2.4 Pheromone Sprays
- 1.2.5 Anxiety Vests
- 1.3 Calming Aids for Dogs Market by Application
- 1.3.1 Global Calming Aids for Dogs Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pet Shop
- 1.3.3 Pet Hospitals and Clinics
- 1.3.4 Household
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Calming Aids for Dogs Market Dynamics
- 2.1 Calming Aids for Dogs Industry Trends
- 2.2 Calming Aids for Dogs Industry Drivers
- 2.3 Calming Aids for Dogs Industry Opportunities and Challenges
- 2.4 Calming Aids for Dogs Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Calming Aids for Dogs Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Calming Aids for Dogs Revenue by Region
- 3.2.1 Global Calming Aids for Dogs Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Calming Aids for Dogs Revenue by Region (2021-2026)
- 3.2.3 Global Calming Aids for Dogs Revenue by Region (2027-2032)
- 3.2.4 Global Calming Aids for Dogs Revenue Market Share by Region (2021-2032)
- 3.3 Global Calming Aids for Dogs Sales Estimates and Forecasts 2021-2032
- 3.4 Global Calming Aids for Dogs Sales by Region
- 3.4.1 Global Calming Aids for Dogs Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Calming Aids for Dogs Sales by Region (2021-2026)
- 3.4.3 Global Calming Aids for Dogs Sales by Region (2027-2032)
- 3.4.4 Global Calming Aids for Dogs Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Calming Aids for Dogs Revenue by Manufacturers
- 4.1.1 Global Calming Aids for Dogs Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Calming Aids for Dogs Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Calming Aids for Dogs Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Calming Aids for Dogs Sales by Manufacturers
- 4.2.1 Global Calming Aids for Dogs Sales by Manufacturers (2021-2026)
- 4.2.2 Global Calming Aids for Dogs Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Calming Aids for Dogs Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Calming Aids for Dogs Sales Price by Manufacturers (2021-2026)
- 4.4 Global Calming Aids for Dogs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Calming Aids for Dogs Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Calming Aids for Dogs Manufacturers, Product Type & Application
- 4.7 Global Calming Aids for Dogs Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Calming Aids for Dogs Market CR5 and HHI
- 4.8.2 2025 Calming Aids for Dogs Tier 1, Tier 2, and Tier 3
5 Calming Aids for Dogs Market by Type
- 5.1 Global Calming Aids for Dogs Revenue by Type
- 5.1.1 Global Calming Aids for Dogs Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Calming Aids for Dogs Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Calming Aids for Dogs Revenue Market Share by Type (2021-2032)
- 5.2 Global Calming Aids for Dogs Sales by Type
- 5.2.1 Global Calming Aids for Dogs Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Calming Aids for Dogs Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Calming Aids for Dogs Sales Market Share by Type (2021-2032)
- 5.3 Global Calming Aids for Dogs Price by Type
6 Calming Aids for Dogs Market by Application
- 6.1 Global Calming Aids for Dogs Revenue by Application
- 6.1.1 Global Calming Aids for Dogs Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Calming Aids for Dogs Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Calming Aids for Dogs Revenue Market Share by Application (2021-2032)
- 6.2 Global Calming Aids for Dogs Sales by Application
- 6.2.1 Global Calming Aids for Dogs Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Calming Aids for Dogs Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Calming Aids for Dogs Sales Market Share by Application (2021-2032)
- 6.3 Global Calming Aids for Dogs Price by Application
7 Company Profiles
- 7.1 Zoetis
- 7.1.1 Zoetis Company Information
- 7.1.2 Zoetis Business Overview
- 7.1.3 Zoetis Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Zoetis Calming Aids for Dogs Product Portfolio
- 7.1.5 Zoetis Recent Developments
- 7.2 Shangrao Chunyu Technology
- 7.2.1 Shangrao Chunyu Technology Company Information
- 7.2.2 Shangrao Chunyu Technology Business Overview
- 7.2.3 Shangrao Chunyu Technology Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolio
- 7.2.5 Shangrao Chunyu Technology Recent Developments
- 7.3 Shandong Youmi Le Health Technology
- 7.3.1 Shandong Youmi Le Health Technology Company Information
- 7.3.2 Shandong Youmi Le Health Technology Business Overview
- 7.3.3 Shandong Youmi Le Health Technology Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolio
- 7.3.5 Shandong Youmi Le Health Technology Recent Developments
- 7.4 Zatural
- 7.4.1 Zatural Company Information
- 7.4.2 Zatural Business Overview
- 7.4.3 Zatural Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Zatural Calming Aids for Dogs Product Portfolio
- 7.4.5 Zatural Recent Developments
- 7.5 Wild One
- 7.5.1 Wild One Company Information
- 7.5.2 Wild One Business Overview
- 7.5.3 Wild One Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Wild One Calming Aids for Dogs Product Portfolio
- 7.5.5 Wild One Recent Developments
- 7.6 Vetoquinol
- 7.6.1 Vetoquinol Company Information
- 7.6.2 Vetoquinol Business Overview
- 7.6.3 Vetoquinol Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Vetoquinol Calming Aids for Dogs Product Portfolio
- 7.6.5 Vetoquinol Recent Developments
- 7.7 ThunderEase
- 7.7.1 ThunderEase Company Information
- 7.7.2 ThunderEase Business Overview
- 7.7.3 ThunderEase Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 ThunderEase Calming Aids for Dogs Product Portfolio
- 7.7.5 ThunderEase Recent Developments
- 7.8 This Dog's Life
- 7.8.1 This Dog's Life Company Information
- 7.8.2 This Dog's Life Business Overview
- 7.8.3 This Dog's Life Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 This Dog's Life Calming Aids for Dogs Product Portfolio
- 7.8.5 This Dog's Life Recent Developments
- 7.9 The Anxious Pet
- 7.9.1 The Anxious Pet Company Information
- 7.9.2 The Anxious Pet Business Overview
- 7.9.3 The Anxious Pet Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 The Anxious Pet Calming Aids for Dogs Product Portfolio
- 7.9.5 The Anxious Pet Recent Developments
- 7.10 Purina
- 7.10.1 Purina Company Information
- 7.10.2 Purina Business Overview
- 7.10.3 Purina Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Purina Calming Aids for Dogs Product Portfolio
- 7.10.5 Purina Recent Developments
- 7.11 Primo Pup
- 7.11.1 Primo Pup Company Information
- 7.11.2 Primo Pup Business Overview
- 7.11.3 Primo Pup Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Primo Pup Calming Aids for Dogs Product Portfolio
- 7.11.5 Primo Pup Recent Developments
- 7.12 PetHonesty
- 7.12.1 PetHonesty Company Information
- 7.12.2 PetHonesty Business Overview
- 7.12.3 PetHonesty Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 PetHonesty Calming Aids for Dogs Product Portfolio
- 7.12.5 PetHonesty Recent Developments
- 7.13 Pet Remedy
- 7.13.1 Pet Remedy Company Information
- 7.13.2 Pet Remedy Business Overview
- 7.13.3 Pet Remedy Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Pet Remedy Calming Aids for Dogs Product Portfolio
- 7.13.5 Pet Remedy Recent Developments
- 7.14 Penelope's Bloom
- 7.14.1 Penelope's Bloom Company Information
- 7.14.2 Penelope's Bloom Business Overview
- 7.14.3 Penelope's Bloom Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Penelope's Bloom Calming Aids for Dogs Product Portfolio
- 7.14.5 Penelope's Bloom Recent Developments
- 7.15 NaturVet
- 7.15.1 NaturVet Company Information
- 7.15.2 NaturVet Business Overview
- 7.15.3 NaturVet Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 NaturVet Calming Aids for Dogs Product Portfolio
- 7.15.5 NaturVet Recent Developments
- 7.16 Merck Animal Health
- 7.16.1 Merck Animal Health Company Information
- 7.16.2 Merck Animal Health Business Overview
- 7.16.3 Merck Animal Health Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 Merck Animal Health Calming Aids for Dogs Product Portfolio
- 7.16.5 Merck Animal Health Recent Developments
- 7.17 Maxxidog
- 7.17.1 Maxxidog Company Information
- 7.17.2 Maxxidog Business Overview
- 7.17.3 Maxxidog Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.17.4 Maxxidog Calming Aids for Dogs Product Portfolio
- 7.17.5 Maxxidog Recent Developments
- 7.18 Kradle
- 7.18.1 Kradle Company Information
- 7.18.2 Kradle Business Overview
- 7.18.3 Kradle Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.18.4 Kradle Calming Aids for Dogs Product Portfolio
- 7.18.5 Kradle Recent Developments
- 7.19 Koi CBD
- 7.19.1 Koi CBD Company Information
- 7.19.2 Koi CBD Business Overview
- 7.19.3 Koi CBD Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.19.4 Koi CBD Calming Aids for Dogs Product Portfolio
- 7.19.5 Koi CBD Recent Developments
- 7.20 King Kanine
- 7.20.1 King Kanine Company Information
- 7.20.2 King Kanine Business Overview
- 7.20.3 King Kanine Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.20.4 King Kanine Calming Aids for Dogs Product Portfolio
- 7.20.5 King Kanine Recent Developments
- 7.21 Heavenly Hounds
- 7.21.1 Heavenly Hounds Company Information
- 7.21.2 Heavenly Hounds Business Overview
- 7.21.3 Heavenly Hounds Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.21.4 Heavenly Hounds Calming Aids for Dogs Product Portfolio
- 7.21.5 Heavenly Hounds Recent Developments
- 7.22 FOMO Bones
- 7.22.1 FOMO Bones Company Information
- 7.22.2 FOMO Bones Business Overview
- 7.22.3 FOMO Bones Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.22.4 FOMO Bones Calming Aids for Dogs Product Portfolio
- 7.22.5 FOMO Bones Recent Developments
- 7.23 Extract Labs
- 7.23.1 Extract Labs Company Information
- 7.23.2 Extract Labs Business Overview
- 7.23.3 Extract Labs Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.23.4 Extract Labs Calming Aids for Dogs Product Portfolio
- 7.23.5 Extract Labs Recent Developments
- 7.24 ElleVet Sciences
- 7.24.1 ElleVet Sciences Company Information
- 7.24.2 ElleVet Sciences Business Overview
- 7.24.3 ElleVet Sciences Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.24.4 ElleVet Sciences Calming Aids for Dogs Product Portfolio
- 7.24.5 ElleVet Sciences Recent Developments
- 7.25 Elanco
- 7.25.1 Elanco Company Information
- 7.25.2 Elanco Business Overview
- 7.25.3 Elanco Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.25.4 Elanco Calming Aids for Dogs Product Portfolio
- 7.25.5 Elanco Recent Developments
- 7.26 Dr. Harvey’s
- 7.26.1 Dr. Harvey’s Company Information
- 7.26.2 Dr. Harvey’s Business Overview
- 7.26.3 Dr. Harvey’s Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.26.4 Dr. Harvey’s Calming Aids for Dogs Product Portfolio
- 7.26.5 Dr. Harvey’s Recent Developments
- 7.27 Ceva
- 7.27.1 Ceva Company Information
- 7.27.2 Ceva Business Overview
- 7.27.3 Ceva Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.27.4 Ceva Calming Aids for Dogs Product Portfolio
- 7.27.5 Ceva Recent Developments
- 7.28 Boehringer Ingelheim
- 7.28.1 Boehringer Ingelheim Company Information
- 7.28.2 Boehringer Ingelheim Business Overview
- 7.28.3 Boehringer Ingelheim Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.28.4 Boehringer Ingelheim Calming Aids for Dogs Product Portfolio
- 7.28.5 Boehringer Ingelheim Recent Developments
- 7.29 Ark Naturals
- 7.29.1 Ark Naturals Company Information
- 7.29.2 Ark Naturals Business Overview
- 7.29.3 Ark Naturals Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.29.4 Ark Naturals Calming Aids for Dogs Product Portfolio
- 7.29.5 Ark Naturals Recent Developments
- 7.30 Adaptil
- 7.30.1 Adaptil Company Information
- 7.30.2 Adaptil Business Overview
- 7.30.3 Adaptil Calming Aids for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.30.4 Adaptil Calming Aids for Dogs Product Portfolio
- 7.30.5 Adaptil Recent Developments
8 North America
- 8.1 North America Calming Aids for Dogs Market Size by Type
- 8.1.1 North America Calming Aids for Dogs Revenue by Type (2021-2032)
- 8.1.2 North America Calming Aids for Dogs Sales by Type (2021-2032)
- 8.1.3 North America Calming Aids for Dogs Price by Type (2021-2032)
- 8.2 North America Calming Aids for Dogs Market Size by Application
- 8.2.1 North America Calming Aids for Dogs Revenue by Application (2021-2032)
- 8.2.2 North America Calming Aids for Dogs Sales by Application (2021-2032)
- 8.2.3 North America Calming Aids for Dogs Price by Application (2021-2032)
- 8.3 North America Calming Aids for Dogs Market Size by Country
- 8.3.1 North America Calming Aids for Dogs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Calming Aids for Dogs Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Calming Aids for Dogs Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Calming Aids for Dogs Market Size by Type
- 9.1.1 Europe Calming Aids for Dogs Revenue by Type (2021-2032)
- 9.1.2 Europe Calming Aids for Dogs Sales by Type (2021-2032)
- 9.1.3 Europe Calming Aids for Dogs Price by Type (2021-2032)
- 9.2 Europe Calming Aids for Dogs Market Size by Application
- 9.2.1 Europe Calming Aids for Dogs Revenue by Application (2021-2032)
- 9.2.2 Europe Calming Aids for Dogs Sales by Application (2021-2032)
- 9.2.3 Europe Calming Aids for Dogs Price by Application (2021-2032)
- 9.3 Europe Calming Aids for Dogs Market Size by Country
- 9.3.1 Europe Calming Aids for Dogs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Calming Aids for Dogs Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Calming Aids for Dogs Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Calming Aids for Dogs Market Size by Type
- 10.1.1 China Calming Aids for Dogs Revenue by Type (2021-2032)
- 10.1.2 China Calming Aids for Dogs Sales by Type (2021-2032)
- 10.1.3 China Calming Aids for Dogs Price by Type (2021-2032)
- 10.2 China Calming Aids for Dogs Market Size by Application
- 10.2.1 China Calming Aids for Dogs Revenue by Application (2021-2032)
- 10.2.2 China Calming Aids for Dogs Sales by Application (2021-2032)
- 10.2.3 China Calming Aids for Dogs Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Calming Aids for Dogs Market Size by Type
- 11.1.1 Asia Calming Aids for Dogs Revenue by Type (2021-2032)
- 11.1.2 Asia Calming Aids for Dogs Sales by Type (2021-2032)
- 11.1.3 Asia Calming Aids for Dogs Price by Type (2021-2032)
- 11.2 Asia Calming Aids for Dogs Market Size by Application
- 11.2.1 Asia Calming Aids for Dogs Revenue by Application (2021-2032)
- 11.2.2 Asia Calming Aids for Dogs Sales by Application (2021-2032)
- 11.2.3 Asia Calming Aids for Dogs Price by Application (2021-2032)
- 11.3 Asia Calming Aids for Dogs Market Size by Country
- 11.3.1 Asia Calming Aids for Dogs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Calming Aids for Dogs Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Calming Aids for Dogs Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Calming Aids for Dogs Market Size by Type
- 12.1.1 SAMEA Calming Aids for Dogs Revenue by Type (2021-2032)
- 12.1.2 SAMEA Calming Aids for Dogs Sales by Type (2021-2032)
- 12.1.3 SAMEA Calming Aids for Dogs Price by Type (2021-2032)
- 12.2 SAMEA Calming Aids for Dogs Market Size by Application
- 12.2.1 SAMEA Calming Aids for Dogs Revenue by Application (2021-2032)
- 12.2.2 SAMEA Calming Aids for Dogs Sales by Application (2021-2032)
- 12.2.3 SAMEA Calming Aids for Dogs Price by Application (2021-2032)
- 12.3 SAMEA Calming Aids for Dogs Market Size by Country
- 12.3.1 SAMEA Calming Aids for Dogs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Calming Aids for Dogs Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Calming Aids for Dogs Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Calming Aids for Dogs Value Chain Analysis
- 13.1.1 Calming Aids for Dogs Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Calming Aids for Dogs Production Mode & Process
- 13.2 Calming Aids for Dogs Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Calming Aids for Dogs Distributors
- 13.2.3 Calming Aids for Dogs Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst